Introduction: Pulmonary congestion is a common finding of heart failure (HF), but it remains unclear how pulmonary and heart blood volumes (Vp and Vh, respectively) and extravascular lung water (EVLW) change in stable HF and affect lung function. Methods: Fourteen patients with HF (age 68 ± 11 y, LVEF 33 ± 8%) and 12 control subjects (age 65 ± 9 y) were recruited. A pulmonary function test, thoracic computerized tomographic (CT) scan, and contrast perfusion scan were performed. From the thoracic scan, a histogram of CT attenuation of lung tissue was generated and skew, kurtosis, and full-width half-max (FWHM) calculated as surrogates of EVLW. Blood volumes were calculated from the transit time of the contrast through the great vessels of the heart. Results: Patients with HF had greater Vp and Vh (Vp 0.55 ± 0.21 L vs 0.41 ± 0.13 L; Vh 0.53 ± 0.33 L vs 0.40 ± 0.15 L) and EVLW (skew 3.2 ± 0.5 vs 3.7 ± 0.7; kurtosis 19.4 ± 6.6 vs 25.9 ± 9.4; FWHM 73 ± 13 HU vs 59 ± 9 HU). Spirometric measures were decreased in HF (percentage of predicted: forced vital capacity 86 ± 17% vs 104 ± 9%; forced expiratory volume in 1 second 83 ± 20% vs 105 ± 11%; maximal midexpiratory flow 82 ± 42% vs 115 ± 43%). Vp was associated with decreased expiratory flows, and EVLW was associated with decreased lung volumes. Conclusions: Congestion in stable patients with HF includes expanded Vp and Vh and increased EVLW associated with reductions in lung volumes and expiratory flows. (J Cardiac Fail 2017;23:690-696) 
Pulmonary congestion is a common clinical complication of heart failure (HF) as a result of the close functional relationship between the heart and lungs. The failing left ventricle causes altered hemodynamics that lead to accumulation of blood centrally. 1 This accumulated blood may contribute to elevated pulmonary wedge pressure, engorgement of the pulmonary vasculature, bronchial vasculature, and capillaries, increased transudation of fluid into the interstitial space, and increased extravascular lung water (EVLW). 2, 3 Because the lung has the ability to efficiently clear fluid away from the gas-exchanging region of the alveoli and prevent the formation of edema, the degree to which EVLW persists in stable disease remains unclear. 4, 5 Overall, the degree to which these blood volumes and extravascular fluid are affected in stable chronic disease and contribute to the congestive state is poorly defined.
Pulmonary function deteriorates in HF with significant heterogeneity between individuals. Patients with HF often exhibit changes that are both restrictive-reductions in forced vital capacity (FVC) and total lung capacity-and obstructivereductions in peak expiratory flow (PEF) and maximal midexpiratory flow (FEF25-75). [6] [7] [8] Patients with HF also exhibit changes in lung compliance, altered ventilatory control, and poor exertional tolerance. 2, 9, 10 These functional limitations contribute to the symptoms of dyspnea and are associated with the development of pulmonary congestion.
It has long been understood that the accumulation of fluid in the lungs results in symptoms associated with HF. In patients with HF who have become acutely decompensated, fluid accumulation in both the lung extravascular space and the lymphatics causes symptoms of dyspnea and exercise intolerance that requires in-patient diuretic treatment to return fluid levels to baseline conditions. 11, 12 Constriction of the bronchial vasculature with the use of methoxamine was shown to improve exercise tolerance in subjects with stable chronic HF, highlighting the importance of bronchial circulation in this population. 13, 14 In healthy subjects, rapid fluid loading has been shown to reduce lung volumes and forced expiratory flows, and heart transplantation in patients with severe disease, subsequently reducing pulmonary pressures, improves these same measures, suggesting that either thoracic blood volumes or EVLW may contribute to changes in lung function. 15, 16 In addition, the heart and lungs must compete for space within the thoracic cavity, where cardiomegaly and/or other changes in vascular beds may impinge on the ability of the lungs to expand. 17 Modulation of thoracic fluid volumes affect pulmonary function in HF, but the degree to which pulmonary congestion persists in the stable HF population and how various fluid compartments within the thorax impact lung function are not clear. There are a number of compartments that have been implicated as contributors, including the larger pulmonary vessels, the capillaries, the heart, and the extravascular space. Some of these central fluid volumes have been shown to be elevated in chronic heart failure, but their link to changes in pulmonary function has not been clearly investigated.
The purpose of the present study was to (a) define how various thoracic fluid volumes, specifically the thoracic, pulmonary, and heart blood volumes and EVLW, are affected in patients with stable chronic systolic HF and (b) determine the relationship between these volumes and changes in lung function in stable chronic patients with HF. We hypothesized that stable chronic patients with HF would have increased thoracic, pulmonary, and heart blood volumes and greater levels of EVLW than the control group resulting in decreased pulmonary function. Further, we hypothesized that the pulmonary blood volume would be associated with obstructive changes in lung function, while EVLW would be associated with restrictive changes in lung function.
Methods

Participants
Fourteen patients with a history of HF and 12 age-matched control subjects were recruited for this study; their characteristics are reported in Table 1 . Patients had ≥1 year of disease history and were on stable medication for ≥1 month, had left ventricular ejection fraction of <40%, a body mass index (BMI) of <35 kg/m 2 , and no history of pulmonary or renal disease. Subjects had a range of clinical severity with New York Heart Association functional classes of I, II, and III. Control subjects had no history of cardiovascular, respiratory, or metabolic disease and BMIs <35 kg/m 2 . The study protocol obtained Mayo Clinic Institutional Review Board approval, and informed written consent was obtained from each subject before participation.
Overview of Experimental Procedures
All experimental procedures were conducted within a single day. A venipuncture blood draw was performed to obtain a measurement of hemoglobin to rule out anemia and of creatinine to verify adequate renal function. Dynamic pulmonary function tests were performed to assess FVC, forced expiratory volume in 1 second (FEV1), FEV1/FVC, FEF25-75, and PEF according to standard methods. 18 Breath-by-breath measures of minute ventilation (VE), respiratory rate (RR), tidal volume, oxygen consumption (VO2), carbon dioxide production (VCO2), VE/VCO2 ratio, and respiratory exchange ratio (RER) were collected during 6 minutes of resting breathing. A thoracic and electrocardiography (ECG)-gated contrast perfusion computerized tomographic (CT) scan were obtained (see details below).
Computed Tomographic Scanning
All CT scans were performed on the same scanner (Somatom Definition Force; Siemens, Erlangen, Germany). A thoracic CT scan was obtained for semiquantitative measurement of EVLW and for alignment for the ECG-gated contrast perfusion scan. For the perfusion scan, a region of interest (ROI) was chosen that included the vena cava (VC), pulmonary artery (PA), pulmonary vein (PV), and aorta (AO). Subjects were well matched for age, but the patients with heart failure were taller and heavier than the control subjects. No differences were observed between MAP, hemoglobin, or eGFR, but patients with heart failure had greater levels of NT-proBNP. Data are presented as ± SEM. BMI, body mass index; BSA, body surface area, MAP, mean arterial pressure; eGFR, estimated glomerular filtration rate; N-terminal pro-B-type natriuretic peptide; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker. *P < .05 control vs heart failure.
Iodinated contrast (0.33 mL per kg body weight) was infused intravenously at the antecubital fossa. Simultaneously, scanning was initiated, and a scan (11 slices per scan, 4.7 mm per slice) was taken during each diastole over a period of 30 seconds. All scans were performed while the subject was at total lung capacity as confirmed via the Medspira Breath Hold System (Medspira, Minneapolis, Minnesota).
Quantification of Thoracic, Pulmonary, and Blood Volumes
Perfusion scans were used for quantification of blood volumes. ROIs were selected in the VC, PA, PV, and AO, and the change in the CT attenuation while the contrast passed through each region was measured using Analyze software (Mayo Clinic, Rochester, MN). The CT attenuation was converted to contrast concentration (C) with the use of equation 1:
. . (1) Where t is time. 19 The gamma variate curve was fitted to the curve for each ROI with the use of equation 2:
Where a, b, and c are arbitrary fitted constants. 20 The cardiac output (Q) was then calculated from the ROI in the PA with the use of equation 3:
Where M is the mass of contrast agent injected. 21 The mean transit time (MTT) for each ROI was calculated with the use of equation 4:
The thoracic (Vt), pulmonary (Vp), and heart (Vh) blood volumes were calculated with the use of equations 5-7:
Semiquantitative Measurement of EVLW Thoracic CT scans were used for quantification of EVLW. Lung tissue was segmented from surrounding tissue and large blood vessels automatically with the use of Matlab built-in active contour algorithms (Mathworks, Natick, Massachusetts). Only pixels within the range of −1000 to 0 HU were included in the analysis. The values for the mean, skewness, and kurtosis were calculated from the distribution of CT attenuation within the segmented areas. The CT attenuation of volume within the lung varies from −1000 HU (corresponding to pure air) to 0 HU (corresponding to pure water), with most voxels having a value between these extremes because they contain a combination of air and water. If more of the voxels within the lung volume have an CT attenuation closer to −1000 HU, the lung volume is relatively drier, and as more water accumulates in the lung, more voxels will move toward 0 HU. This is quantified through the mean, skewness, kurtosis, and full-width half-max (FWHM), where the curve is skewed to the left, has a high kurtosis, and is narrow when the lung is dry. Conversely, as EVLW accumulates, the mean shifts to the right, the skew decreases, the kurtosis decreases, and the FWHM increases as more voxels within the lung space are closer to 0 HU.
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Statistical Analysis
Statistical analysis was carried out in SPSS v20 (IBM, Chicago, Illinois). The independent-samples Mann-Whitney U test was used to compare subject demographics, gas exchange, blood volumes, EVLW measurements, and pulmonary function between patients with HF and age-matched control subjects. In addition, Cohen d was computed for blood volumes and EVLW to show effect size of the respective differences. 25 The interrelationships between blood volumes, EVLW, and indexes of pulmonary function were assessed via linear regression. Corrections for multiple comparisons were not made. Demographic and gas exchange data are presented as mean ± SEM, pulmonary function measures are expressed as mean ± SEM, and blood volumes and extravascular lung water measurements are expressed as median (interquartile range). Statistical significance was accepted if P < .05.
Results
Pulmonary Gas Exchange
Measurements of resting gas exchange and breathing pattern are reported in Table 2 . VE was greater in patients with HF compared with healthy control subjects (P < .05); all other resting ventilatory and gas exchange indices were similar between the groups. No differences were observed between the groups, except for patients with HF having greater minute ventilation. Data are presented as mean ± SEM. VO2, oxygen consumption; VCO2, carbon dioxide production; RER, respiratory exchange ratio ; RR, respiratory rate; VE, minute ventilation. *P < .05.
Thoracic Blood Volumes
Thoracic, pulmonary, and heart blood volumes were greater in the HF group in absolute terms (Vt 1090 ± 530 mL vs 810 ± 250 mL; Vp 550 ± 210 mL vs 410 ± 130 mL; Vh 540 ± 350 mL vs 400 ± 150 mL; P < .05). To account for differences in body size, Vt, Vp, and Vh normalized to body surface area (BSA) are reported in Table 3 . All 3 blood volumes were greater in the patients with HF when normalized to BSA. The effect size was considered to be large for the Vt and Vp and medium for Vh, suggesting that there is a consistent difference in these blood volumes for the 2 populations.
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CT Quantitative Indices
The average CT attenuation distribution for both groups is shown in Fig. 1 . The mean, skew, kurtosis, and FWHM are presented in Table 4 . The HF group had distributions that were less negative, less skewed, and wider, suggesting greater levels of EVLW. In addition, the effect size for all 4 measurements was large, suggesting that these measurements differentiate well between groups.
Pulmonary Function
Pulmonary function measurements for both groups are shown in Fig. 2 . Absolute and percentage of predicted FVC, FEV1, FEF25-75, and PEF were lower in patients with HF compared with healthy control subject (P < .05). In contrast, FEV1/ FVC was not different between the groups.
Relationship Between Thoracic Blood Volumes and EVLW and Pulmonary Function
Correlations between thoracic blood volumes and EVLW and pulmonary function measurements are reported in Table 5 . In the control group, only thoracic blood volume was significantly correlated with FEV1. In the HF group, FVC was significantly related to the mean, skew, kurtosis, and FWHM and FEV1 was related to the skew and kurtosis, with greater levels of EVLW associated with decreased lung volumes. FEV1/FVC was inversely and significantly correlated with Vt, Vp, and Vh, and PEF was inversely correlated with Vt and Vp. Less negative mean, lower skew and kurtosis, and higher FWHM suggest greater levels of extravascular lung water. Patients with heart failure had greater levels of extravascular lung water as indicated by the difference in skew, kurtosis, and FWHM. Data are presented as median (interquartile range). FWHM, full-width half-max. Greater volumes of blood were associated with decreased pulmonary function. FEF25-75 was not associated with any measures of thoracic blood volume or EVLW in either group.
Discussion
Pulmonary congestion is a common, complicated manifestation of the pathophysiology of HF. In the present study, we sought to quantify thoracic, pulmonary, and heart blood volumes with the use of a CT contrast perfusion method as well as to semiquantitatively determine EVLW to understand each compartment's contribution to "pulmonary congestion" in a stable chronic HF population and to understand their respective effects on lung function. We found that the HF population had increases in thoracic, pulmonary, and heart blood volumes, increased EVLW, and impaired lung function compared with control subjects. Greater pulmonary blood volume was associated with obstructive changes in the lungs and decreases in FEV1/FVC and PEF, and increased EVLW was related to restrictive lung changes and reductions in FVC and FEV1. Thus, even in stable chronic HF, there are expanded thoracic, pulmonary, and heart blood volumes as well as evidence for increased EVLW consistent with subclinical edema. Each of these changes appears to negatively affect and contribute to the symptomology of HF.
Thoracic Blood Volumes
Traditionally, EVLW has been thought to be the main contributor to pulmonary congestion. 26 In our view, the expansion of the pulmonary vascular blood volume also contributes to the loss of pulmonary function. Thoracic blood volumes have been quantified in a number of ways to investigate if these compartments change with the progression of HF and other diseases. To our knowledge, we are the first to quantify these fluid compartments with the use of the CT contrast perfusion technique described here, which is less invasive than previously used methods based on invasive indicator dilution. Our findings are quantitatively similar to those from other groups using invasive indicator dilution methods and qualitatively similar to those using positron emission tomography (PET) methods. 27, 28 We found that increased thoracic, pulmonary, and heart blood volumes were associated with reductions in FEV1/FVC ratio and PEF. There are several possible explanations for this result. Increases in pulmonary vascular volume may cause compression of the airways. Various studies in humans and other animals after rapid fluid loading have shown that small vessels near small airways become engorged and edema forms in the airway walls, but that airways cross sectional area was maintained. [29] [30] [31] One study in dogs with the use of CT scanning found~20% reduction in airway area with saline solution infusion. 32 A previous study in our laboratory found small reductions in the luminal airway of the large airways after fluid loading but no differences in large airways in patients with HF. 15, 33 These divergent findings confound the understanding of the relationship between pulmonary function and thoracic blood volumes that were found in the present study. It is possible that edema formation in the small bronchioles changes their structural properties, making them more susceptible to collapse, or causes changes in the luminal walls, leading to increased airway resistance. In either case, the equal pressure point would move distally and create greater flow limitations.
It has been previously shown that heart volume can be a factor associated with reduced lung volumes; however, we did not observe that relationship in the present study. 17, 34 The relationship was likely not found because only the blood volume within the heart was measured as opposed to the entire heart volume. Radiographically determined measures of heart volume are more predictive than echocardiographically determined measures owing to incorporation of the entire cardiac mass versus assessment of individual chambers. 35 Given that the measure described here measured only the blood within the heart chambers, it would be expected to have poor predictive value for the lung volumes.
Extravascular Lung Water
EVLW is traditionally thought of as the main contributor to pulmonary congestion in HF. A histogram technique to Blood volumes were associated with obstructive changes in expiratory flows and EVLW with restrictive changes in lung volumes in the patients with heart failure but not in the control subjects. Abbreviations as in Fig. 2 . *P < .05. semiquantitatively measure differences in EVLW was used. 23, 33, 36 Decreased skew and kurtosis and increased FWHM, as found here, suggest the presence of additional EVLW in stable chronic patients with HF compared with control subjects. This qualitatively matches the findings from other laboratories that used direct measures, such as indicator dilution and PET techniques, and found increased EVLW in patients with HF. 37, 38 This increased water likely forms because of increased pulmonary wedge pressure. No differences were found in the resting gas-exchange measures, suggesting the increased EVLW is not present in the alveoli and is being diverted to the thick side of the alveoli-capillary membrane to the lymphatic system.
In the present study, a relationship was found between increased levels of EVLW, as measured by the CT indexes, and restrictive changes in lung function, as indicated by decreased FVC and FEV1. Increased EVLW has been linked to changes in pulmonary mechanics, specifically decreased compliance, which would limit lung volumes, and is related to the degree of EVLW present. 39 Overall, increased EVLW seems to be a factor in reduced lung volumes in stable chronic HF.
Study Limitations
Four major points must be considered when interpreting the findings of the present study. First, the patients with HF were taller and weighed more than the control subjects. To account for these factors, we normalized our thoracic, pulmonary, and heart blood volumes to the subjects' BSA and exclusively used percentage of predicted for pulmonary function measures. Second, the method used to measure EVLW does not provide a quantitative measure and may be susceptible to changes in tissue or blood volume. Although we found increased pulmonary blood volume, most of this would be excluded by the segmentation process before histogram generation and calculation of the quantitative indexes. In addition, studies have found no difference in capillary blood volumes between HF and control subjects; these factors suggest that this method is primarily measuring differences in water content. 40 Third, in some subjects, there was incomplete washout of the dye from the aorta during the 30-second scanning period. All subjects reached the downward slope of the contrast washout curve, but fitting errors could still exist as a result of extrapolation. However, the extrapolated curves were qualitatively similar to those fitted to a complete dataset, suggesting that the error was small. Finally, we chose not to correct for multiple comparisons owing to a concern that false negatives could limit further investigation into these factors as causes of reduced function in HF, the fact that a false discovery rate was not determined before data collection, and the relatively small sample size of the present study. Additionally, the large effects sizes suggest that these findings represent important consistent differences between HF and control subjects.
Conclusion
In the present study, we sought to better define pulmonary congestion in stable patients with HF by examining both thoracic blood volumes and EVLW. The thoracic, pulmonary, and heart blood volumes were quantified with the use of a novel CT contrast-based approach. We determined that thoracic, pulmonary, and heart blood volumes and EVLW were increased in patients with stable chronic HF. Symptoms consistent with pulmonary congestion, such as decreased lung volumes and flows, were observed. Overall, stable chronic patients with HF had evidence of mild increases in EVLW that were associated with a reduction in lung volumes and thoracic blood volumes that were were linked to reduced forced expiratory flows. Although EVLW is a recognized sequela of pulmonary congestion in a more acute decompensated state, our results suggest that vascular volumes are expanded in the thorax, that EVLW is elevated, and that both contribute to the altered lung function and symptoms of moderate chronic HF.
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